Riskpilot← Back to searchSign inGet full accessNW Medicin AB
ABActiveOrg 5593496465Pålängeån 226Hospital activities · NACE 8610Est. 20211-4 employees
Revenue 2025
SEK 517K
-27% vs 2024
EBITDA margin
-31.3%
-142% vs 2024
Equity ratio
49.6%
Financial strength
Net profit 2025
SEK -78K
-138% vs 2024
| Revenue | SEK 517K | -27% |
| EBITDA | SEK -162K | -142% |
| Net profit | SEK -78K | -138% |
| Total assets | SEK 278K | -47% |
| Equity | SEK 138K | -46% |
| Employees | — | — |
Legal name
NW Medicin AB
Org number
5593496465
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
30 november 2021
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva hälso- och sjukvårdsverksamhet med därmed förenlig verksamhet samt tillverkning och försäljning av keramiska hushålls- och prydnadsartiklar.
Address
Pålängeån 226
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 311 | 709 | 517 |
| Staff expenses | — | −1 | −159 | — |
| EBITDA | −24 | 132 | 390 | −162 |
| Depreciation & amort. | −1 | −2 | −19 | −33 |
| EBIT | −25 | 130 | 371 | −195 |
| Net financials | — | −0 | −0 | −2 |
| Profit before tax | −25 | 104 | 259 | −78 |
| Tax | — | −16 | −55 | −0 |
| Net profit | −25 | 87 | 204 | −78 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 49 | 309 | 528 | 278 |
| Equity | 25 | 113 | 256 | 138 |
| Long-term debt | 18 | 131 | 52 | 25 |
| Short-term debt | 5 | 38 | 82 | 115 |
| Total debt | 23 | 170 | 134 | 140 |
EBITDA margin
-31.3%
This company
15.8%
Market median
-298% vs market
20222025
Equity ratio
49.6%
This company
38.2%
Market median
+30% vs market
20222025
Return on equity
-56.5%
This company
18.4%
Market median
-407% vs market
20222025
Net profit margin
-15.1%
This company
8.1%
Market median
-286% vs market
20222025
Asset turnover
1.86×
This company
1.12×
Market median
+66% vs market
20222025
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-30 – 2022-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NW Medicin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Matilda Elisabet Wikström | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Nils Gustav Wikström | Board of Directors | 0 companies |
| Mikaela Jenni Berglund | Deputy Board Member | 0 companies |